🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the side effects and best dose of linsitinib ...
Status
Withdrawn
Location
OHSU Knight Cancer Institute
Start Date
2011-12
Trial ID
NCT01465815
The purpose of this study is to evaluate the effect of combining a new inve...
Status
Terminated
Location
Emory University Winship Cancer Institute
Start Date
2011-03
Trial ID
NCT01334710
Treatments Being Tested
This study plans to learn more about an investigational drug called OSI-906...
Status
Terminated
Location
University of Colorado Denver
Start Date
2009-12
Trial ID
NCT01016860
Treatments Being Tested
This phase II trial studies how well linsitinib works in treating younger a...
Status
Completed
Location
Stanford Cancer Institute
Start Date
2012-03
Trial ID
NCT01560260
Treatments Being Tested
Erlotinib attacks a part of cancer cells that helps them live and grow. Stu...
Status
Terminated
Location
Vanderbilt-Ingram Oncology Cool Springs
Start Date
2010-05
Trial ID
NCT01205685
Multicenter, open-label, phase 1, cohort dose escalation study to determine...
Status
Completed
Location
Vanderbilt Universtiy Medical Center
Start Date
2007-06-18
Trial ID
NCT00514007
Treatments Being Tested
The purpose of this study is to provide access to continued treatment for s...
Status
Completed
Location
Site US10004
Start Date
2014-04-16
Trial ID
NCT02057380
Treatments Being Tested
This is a multi-center, open-label, non-randomized study. Patients will rec...
Status
Terminated
Location
Emory University Winship Cancer Institute
Start Date
2012-09
Trial ID
NCT01672736
Treatments Being Tested
This phase II trial studies how well linsitinib works in treating patients ...
Status
Completed
Location
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2012-02
Trial ID
NCT01533246
Treatments Being Tested
The goal of this clinical research study is to learn if the addition of OSI...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01427205